EndoSphere showcases its Satisphere Device at OneMedForum
EndoSphere’s Novel Solution Recognized as Game-Changing Innovation for Treating Obesity and Type 2 Diabetes
San Francisco, CA January 8, 2013 - EndoSphere, Inc., a medical technology company focused on the non-invasive treatment of Metabolic Diseases including Obesity and Type 2 Diabetes, announced that CEO James T. McKinley is scheduled to present today at the 6th Annual OneMedForum conference. The January 7-9 conference is being held at the Sir Francis Drake Hotel in San Francisco.
"OneMedPlace is excited to be hosting Jim McKinley and EndoSphere at our 6th Annual OneMedForum,” said OneMedPlace CEO Brett Johnson, “EndoSphere's unique obesity solution makes the company a critical player in the diabetes/obesity space."
For the complete story click here.